https://pharmaqazaqstan.com

International Congress and Exhibition Pharma Qazaqstan & Central AsiaOfficial site of the Congress and Exhibition Pharma Qazaqstan & Central Asia+44 207 394 30 90 (London)International Congress and Exhibition Pharma Qazaqstan & Central Asia СONDITIONS OF PARTICIPATION SUBSCRIBE Expert platform for pharmaceutical leaders Supported in 2024 by: About The Congress Сonditions of Participation Speakers Investment Projects Participants Programme Insights Industry Report Investment Projects Request the brochure Sponsorship Media Partners Contact Us Webinar Previous Events Congress 2024 Congress 2023 3rd International Congress and Exhibition Pharma Qazaqstan & Central Asia 8-9 April 2025, Almaty, Kazakhstan СONDITIONS OF PARTICIPATION BROCHURE Welcome Speech: Dr. Toylan Şenel, Head Roche Central Asia, General Manager Roche Kazakhstan READ MORE About the Congress 200+ PARTICIPANTS 30+ INVESTMENT PROJECTS 2 days OF NETWORKING Pharma Qazaqstan Congress and Exhibition is a unique international platform for leaders of the pharmaceutical industry of Kazakhstan, Uzbekistan, Kyrgyzstan, Tajikistan and other countries of Central Asia which involves senior executives of investment projects and major pharmaceutical plants, government officials, regulators, technology licensors, developers, manufacturers and suppliers of equipment, engineering and construction companies, technology and service providers. The event is devoted to discussion of major investment projects on construction of production capacities, to efficiency boosting options of pharmaceuticals production. REQUEST THE BROCHURE PHOTO REPORT VIDEO REPORT LEAVE FEEDBACK Among the speakers and VIP guests 2024 Dr. Toylan Şenel Head Roche Central Asia, General Manager Roche Kazakhstan Dr. Toylan Şenel Head Roche Central Asia, General Manager Roche Kazakhstan Mariya Shipuleva General Director AstraZeneca Mariya Shipuleva General Director AstraZeneca Galimzhan Kozhakanov General Director Sandoz Kazakhstan Galimzhan Kozhakanov General Director Sandoz Kazakhstan Yelena Lee Founder Dolce Yelena Lee Founder Dolce Evgeniy Zemlyankin General Director AMITY International Evgeniy Zemlyankin General Director AMITY International Bikesh Kurmangalieva General Director Centre for Digital Economy Development Bikesh Kurmangalieva General Director Centre for Digital Economy Development Saida Yerdenbekova Business Development Director Medservice Plus Saida Yerdenbekova Business Development Director Medservice Plus Murat Baydildaev Director of the Representative Office of the Pharmaceutical Plant CJSC Egis Kazakhstan Murat Baydildaev Director of the Representative Office of the Pharmaceutical Plant CJSC Egis Kazakhstan Olga Sermukhamedova Director Fitoleum Olga Sermukhamedova Director Fitoleum REQUEST THE FULL LIST OF SPEAKERS Among the regular participants JOIN THE CONGRESS REQUEST THE FULL LIST Join Us! 8-9 April 2025, Almaty, Kazakhstan Directions Major Investment Projects MODERNIZATION OF THE PLANT FOR THE PRODUCTION OF MEDICAL PREPARATIONS IN ALMATY REGION MODERNIZATION OF THE PLANT FOR THE PRODUCTION OF MEDICAL PREPARATIONS IN ALMATY REGION Operator/initiator: KFK MEDSERVICE PLYUS Location: Almaty region Stage: Documentation and search for contractors Dates: 4th quarter of 2022 – 4th quarter of 2027 Investment amount: 11,77 million US dollars The project is aimed at the modernisation of the plant and the production of high-quality products. LOCALISATION OF MEDICINES PRODUCTION IN THE REPUBLIC OF KAZAKHSTAN LOCALISATION OF MEDICINES PRODUCTION IN THE REPUBLIC OF KAZAKHSTAN Operator/initiator: Roche Holding Stage: Planned Dates: 2023–2024 Investment amount: Not clarified A project aimed at the localisation of the production of innovative original medicines for the treatment of cancer. CONSTRUCTION OF PHARMACEUTICAL PLANT IN ALMATY: PRODUCTION OF PREPARATIONS IN THE FORM OF SACHETS AND HIGH-TECH BIOSIMILARS CONSTRUCTION OF PHARMACEUTICAL PLANT IN ALMATY: PRODUCTION OF PREPARATIONS IN THE FORM OF SACHETS AND HIGH-TECH BIOSIMILARS Operator/initiator: Nobel AFF Stage: Development of design and estimate documentation, feasibility study Dates: 2022–2025 Investment amount: 55 million US dollars The company will contribute to the development of domestic production of original medical preparations and medical devices, increase the export potential of domestic pharmaceutical products, as well as increase scientific and human potential. CONSTRUCTION OF PLANT FOR THE PRODUCTION OF BIOPHARMACEUTICALS CONSTRUCTION OF PLANT FOR THE PRODUCTION OF BIOPHARMACEUTICALS Operator/initiator: GL Rapha Stage: Planned Dates: 2023–2025 Investment amount: 40 million US dollars It is planned to launch a plant for the contract production of antitumor preparations in Kazakhstan. EXPANSION OF THE EXISTING PRODUCTION OF MEDICAL PREPARATIONS, AS WELL AS HIP AND KNEE JOINT ENDOPROSTHESES EXPANSION OF THE EXISTING PRODUCTION OF MEDICAL PREPARATIONS, AS WELL AS HIP AND KNEE JOINT ENDOPROSTHESES Operator/initiator: LLP Sultan Location: Almaty region Stage: Planned Investment amount: 18,137 million US dollars The company has a land plot of 1 hectare and capital buildings with a total area of 5,000 sq. m. (including a building for the production of medical preparations and a workshop for the production of endoprostheses with an area of 2,500 sq. m. and 500 sq. m., respectively). The development of the project will reduce the country’s import dependence on medical preparations and artificial prostheses. PRODUCTION OF SYRINGES IN ALMATY REGION PRODUCTION OF SYRINGES IN ALMATY REGION Operator/initiator: LLP Dolce Location: Almaty region, Special Economic Zone Park of Innovative Technologies Stage: Planned Investment amount: 5, 731 million US dollars As part of the project, it is planned to build a syringe production plant with a capacity of 285 million units of products annually. The production will be localised in the special economic zone Park of Innovative Technologies in the Almaty region. The land plot is 5 hectares, the area of industrial premises is 4,000 sq. m. REQUEST THE FULL LIST OF INVESTMENT PROJECTS Congress Highlights 2024 200+ senior executives of the largest pharmaceutical companies will come together on one platform to discuss the most pressing issues in the industry! 20+ reports with up-to-date information from senior executives of key companies in the industry 30+ largest projects of industry leaders. Demonstration of the development of pharmaceutical plants, plans and projects for the construction of new facilities in Kazakhstan Presentation of the latest technologies for the construction, modernisation and equipping of pharmaceutical facilities. What are the main stages and tasks in equipping pharmaceutical production facilities? BIG PHARMA: Contract production and transfer of technologies Design and construction of pharmaceutical production facilities: compliance with local and international standards, regulatory and normative aspects TRACK & TRACE. Serialisation and labeling of medical preparations in Kazakhstan and Central Asian countries: progress in introduction of the system and the experience of neighboring countries SINGLE MARKET OF THE EAEU. Harmoniыation of the single pharmaceutical market of the EAEU, bringing registration dossiers into compliance with the requirements and cooperation of manufacturers within the EAEU Discussion of wholesale and retail sales of medicines and medical devices: optimisation of logistics, marketing promotion, digitalisation and pricing 30+ hours of business and informal networking! One-on-one meetings, business lunches, coffee breaks, welcome cocktail, and much more REQUEST THE FULL PROGRAMME Industry Insights Industry Report Overview of the industry status and prospects for the development of the pharmaceutical industry in the Republic of Kazakhstan REQUEST Investment Projects Major investment projects for the construction and modernisation of pharmaceutical plants in the Republic of Kazakhstan REQUEST Event Brochure Facts and figures of the industry, congress programme highlights, and a lot more about the congress REQUEST Sponsors and Partners 2024 SILVER SPONSORS: BRONZE SPONSORS: BECOME A SPONSOR BECOME A PARTNER Request Сonditions of participation Full Name Company Job title Mobile phone Work email Please note that due to our internal policy we are not entitled to send any materials to personal emails (Yahoo, Google, etc.) If you have any questions, please contact us: +44 207 394 3090 (London) Where did you hear about this event? Online journal, portalPrint mediaSocial mediaInternetE-shotRecommendation Other I hereby accept the terms of service and confirm my consent to processing and storage of personal data.   OUR BRANDS +44 207 394 30 90 (London) [email protected] www.vostockcapital.com supported by Inventica     Copyright © 2024 - Vostock Capital UK Terms and Conditions of Website Use Privacy Policy and Cookie Policy for Website About The Congress Сonditions of Participation Speakers Investment Projects Participants Programme Insights Industry Report Investment Projects Request the brochure Sponsorship Media Partners Contact Us Webinar Previous Events Congress 2024 Congress 2023 BECOME A SPONSOR MEDIA PARTNERS СONDITIONS OF PARTICIPATION SUBSCRIBE Full Name Company Job title Mobile phone Work email Please note that due to our internal policy we are not entitled to send any materials to personal emails (Yahoo, Google, etc.) If you have any questions, please contact us: +44 207 394 3090 (London) Where did you hear about this event? Online journal, portalPrint mediaSocial mediaInternetE-shotRecommendation Other I hereby accept the terms of service and confirm my consent to processing and storage of personal data.   DISCLAIMER The company takes reasonable measures to ensure the accuracy and timeliness of the content but does not assume responsibility for actions taken by third parties based on the information, whether provided by the company or third parties. The information, opinions, and evaluations contained in the document are not intended for distribution or use by any individual or legal entity in any jurisdiction where it would contravene the law or regulations or require registration or licensing. The company does not claim that the provided information or opinions are true at all times or comprehensive, but they are based on data obtained from reliable sources. The presented information should not be used as the sole guide for making investment decisions.enusen-US1730695471https://pharmaqazaqstan.com

سایت خود را ویرایش کنید؟

چیکار میکنی؟